a bitter proxy battle with Forest Laboratories Inc,
accused the drugmaker of hiding information from shareholders
that might show it has built provisions into its licensing
agreements that would deter a potential suitor.
Friday, August 10, 2012
Icahn accuses Forest of hiding poison pill agreements
Aug 10 (Reuters) - Activist investor Carl Icahn, engaged in
a bitter proxy battle with Forest Laboratories Inc,
accused the drugmaker of hiding information from shareholders
that might show it has built provisions into its licensing
agreements that would deter a potential suitor.
a bitter proxy battle with Forest Laboratories Inc,
accused the drugmaker of hiding information from shareholders
that might show it has built provisions into its licensing
agreements that would deter a potential suitor.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment